PRP / PRF injections in Vejle

PRP (platelet-rich plasma) and PRF (platelet-rich fibrin) are autologous therapies prepared from your own blood. They concentrate platelets and related biological factors and may be considered for selected tendon and joint presentations where a regenerative-support strategy can improve symptom control and functional progression. At Nordivia, PRP/PRF is positioned as a pathway step—not a standalone promise—with clear suitability criteria, ultrasound guidance where appropriate, and milestone-based follow-up focused on measurable functional gains.

At a glance

Who it may suit (suitability-led)

Who it may not suit

How it works (typical pathway)

Outcomes to expect

Response varies by indication, severity, and protocol. The expected value is typically gradual improvement in function and load tolerance rather than instant symptom elimination. We define success metrics upfront—pain trend, flare frequency, walking distance, stairs tolerance, and sport/work capacity—and track progress at planned checkpoints to determine whether the pathway is delivering ROI.

Aftercare and follow-up

Aftercare is designed to convert symptom change into durable capacity gains. Most patients benefit from short-term load management followed by structured progression in strength and tolerance. Follow-up checkpoints validate response, calibrate rehabilitation progression, and define the next best step—continue, adjust, or pivot—based on objective milestones rather than assumptions.

Risks and side effects

Temporary soreness, swelling, stiffness, or a short flare can occur at the injection site. Bruising is possible after blood draw or injection. Uncommon risks include infection, bleeding, or a stronger-than-expected inflammatory response. Site-specific risks and alternatives are reviewed during informed consent, with clear escalation guidance if symptoms change after treatment.

FAQ

Ready for a clear plan?

Book an assessment to review suitability and build a structured pathway

Review fees and how to prepare for your first visit before booking.

Most patients report temporary discomfort during the injection and short-lived post-treatment soreness. We align expectations before treatment and provide aftercare guidance to reduce flare risk and support functional progression.
Both are autologous. PRP is typically a platelet-rich plasma preparation, while PRF forms a fibrin matrix that can release biological factors over time. The best choice depends on the target tissue, clinical objective, and protocol fit—so we select based on indication and pathway goals.
Return is milestone-based, not date-based. We provide a staged plan that typically starts with load management and controlled strengthening, then progresses to sport-specific demands when symptoms are predictable and next-day flares are controlled.
In selected cases, yes. Sequencing is suitability-led and designed to improve functional outcomes—e.g., pairing with rehabilitation, footwear/brace strategy, or other injection options when the risk–benefit profile supports it.
We reassess the diagnosis and dominant driver, then adjust the pathway. This may include refining load strategy, changing the rehabilitation focus, or selecting an alternative conservative step if milestones are not being met.

Medical information is general and does not replace personalised medical advice